Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Abstract
Share and Cite
Elias, M.H.; Baba, A.A.; Husin, A.; Abdullah, A.D.; Hassan, R.; Sim, G.A.; Wahid, S.F.A.; Ankathil, R. Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients. Hematol. Rep. 2012, 4, e23. https://doi.org/10.4081/hr.2012.e23
Elias MH, Baba AA, Husin A, Abdullah AD, Hassan R, Sim GA, Wahid SFA, Ankathil R. Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients. Hematology Reports. 2012; 4(4):e23. https://doi.org/10.4081/hr.2012.e23
Chicago/Turabian StyleElias, Marjanu Hikmah, Abdul Aziz Baba, Azlan Husin, Abu Dzarr Abdullah, Rosline Hassan, Goh Ai Sim, S. Fadilah Abdul Wahid, and Ravindran Ankathil. 2012. "Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients" Hematology Reports 4, no. 4: e23. https://doi.org/10.4081/hr.2012.e23